IMS Health has filed papers for an initial public offering (IPO) that Reuters reports could value the private equity-owned company at $10 billion. The IPO could raise up to $100 million as TPG Capital Funds and other investors look to cash in on the business they took private in 2010 in a $5.2 billion deal. Since then, IMS has made a string of acquisitions to add to its analytics capabilities. Article | Filing